Stockreport

Benitec Biopharma Releases First Quarter 2026 Financial Results and Provides Operational Update [Yahoo! Finance]

Benitec Biopharma Inc.  (BNTC) 
US:NASDAQ Investor Relations: benitec.com/for-investors/investor-faqs
PDF Food and Drug Administration (FDA) review of positive interim clinical study results and proprietary Responder Analysis planned for use in pivotal study for BB-301– –P [Read more]